Safety and efficacy of an all-oral interferon-free regimen of seraprevir, an NS3/4A protease inhibitor and sofosbuvir in patients with chronic hepatitis C virus (HCV) genotype 1: an open-label, multicentre, phase 3 trial
单位:[1]First Hosp Jilin Univ, Hepatol, Changchun, Peoples R China[2]Liuzhou Peoples Hosp, Liuzhou, Peoples R China[3]Xinjiang Uygur Autonomous Reg Tradit Chinese Med, Tibetan, Peoples R China[4]Zunyi Med Coll, Affiliated Hosp, Zunyi, Guizhou, Peoples R China[5]Chongqing Three Gorges Cent Hosp, Chongqing, Peoples R China[6]Chengdu Publ Clin Hlth & Med Ctr, Chengdu, Peoples R China[7]Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China[8]Xuzhou Med Univ, Affiliated Hosp, Xuzhou, Jiangsu, Peoples R China[9]Capital Med Univ, Beijing Youan Hosp, Beijing, Peoples R China[10]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Peoples R China华中科技大学同济医学院附属同济医院[11]Fifth Hosp Wuxi, Wuxi, Jiangsu, Peoples R China[12]Shanxi Med Univ, Hosp 1, Jinzhong, Peoples R China[13]Sichuan Prov Peoples Hosp, Chengdu, Peoples R China四川省人民医院[14]Huzhou City Cent Hosp, Huzhou, Peoples R China[15]Guangxi Med Univ, Hosp 1, Nanning, Peoples R China[16]Hebei Med Univ, Hosp 1, Shijiazhuang, Hebei, Peoples R China[17]Chongqing Publ Clin Hlth & Med Ctr, Chongqing, Peoples R China[18]Capital Med Univ, Beijing Friendship Hosp, Beijing, Peoples R China首都医科大学附属北京友谊医院[19]Qingdao City Cent Hosp, Qingdao, Peoples R China[20]Jinyintan Hosp Wuhan, Wuhan, Peoples R China[21]Southwest Med Univ, Tradit Chinese Med Hosp, Luzhou, Peoples R China[22]Xinjiang Med Univ, Hosp 1, Urumqi, Peoples R China[23]Zhengzhou Sixth Peoples Hosp, Zhengzhou, Peoples R China
第一作者单位:[1]First Hosp Jilin Univ, Hepatol, Changchun, Peoples R China
推荐引用方式(GB/T 7714):
Wen Xiaoyu,Kong Fei,Wen Xiaofeng,et al.Safety and efficacy of an all-oral interferon-free regimen of seraprevir, an NS3/4A protease inhibitor and sofosbuvir in patients with chronic hepatitis C virus (HCV) genotype 1: an open-label, multicentre, phase 3 trial[J].JOURNAL of HEPATOLOGY.2020,73:S330-S330.
APA:
Wen, Xiaoyu,Kong, Fei,Wen, Xiaofeng,Wang, Xiaozhong,Lin, Shide...&Niu, Junqi.(2020).Safety and efficacy of an all-oral interferon-free regimen of seraprevir, an NS3/4A protease inhibitor and sofosbuvir in patients with chronic hepatitis C virus (HCV) genotype 1: an open-label, multicentre, phase 3 trial.JOURNAL of HEPATOLOGY,73,
MLA:
Wen, Xiaoyu,et al."Safety and efficacy of an all-oral interferon-free regimen of seraprevir, an NS3/4A protease inhibitor and sofosbuvir in patients with chronic hepatitis C virus (HCV) genotype 1: an open-label, multicentre, phase 3 trial".JOURNAL of HEPATOLOGY 73.(2020):S330-S330